Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.75 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL1461647 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL986168 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL8636269 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL1147464 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL220582 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL23499010 | 1.00 | TSHR (0.75) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL11564762 | 0.95 | TSHR (0.68) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL23356849 | 0.95 | TSHR (0.68) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL23356752 | 0.95 | TSHR (0.68) | TSHRMEN1KMT2ATHRBHTT | |
| Ethylene Glycol SCHEMBL18784039 | 0.94 | TSHR (0.83) | TSHRMEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287402-A1 | METHODS FOR THE ABATEMENT OF FOULING OF NATURAL GAS PROCESSING EQUIPMENT USING ANTI-FOAM AND DE-FOAMING COMPOSITIONS | ECOLAB USA INC. (US) | 2024-08-29 | — | — | US | claimed |
| WO-2024177820-A1 | METHODS FOR THE ABATEMENT OF FOULING OF NATURAL GAS PROCESSING EQUIPMENT USING ANTI-FOAM AND DE-FOAMING COMPOSITIONS | ECOLAB USA INC. (US) | 2024-08-29 | — | — | WO | claimed |
| US-20140292912-A1 | Liquid Discharge Recording Apparatus and Method for Recovering Liquid | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 2014-10-02 | — | — | US | claimed |
| US-6225263-B1 | INJECTING INTO THE FORMATION, PREFERABLY IN THE FORM OF AN AQUEOUS SOLUTION, AT LEAST ONE MONO ALKYL ETHER OF POLYETHYLENE GLYCOL IN WHICH THE ALKYL GROUP HAS 3-5 CARBONS AND THE POLYETHYLENE GLYCOL CONTAINS 3-6 ETHYLENE OXY UNITS | BP CHEMICALS LIMITED (GB) | 2001-05-01 | — | — | US | claimed |
| US-12597635-B2 | Electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2026-04-07 | — | — | US | disclosed |
| EP-4689022-A1 | ANTIFOULANT COMPOSITIONS AND METHOD FOR MITIGATING FOULING IN NATURAL GAS PROCESSING EQUIPMENT | Ecolab USA, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| CN-119685080-A | Lubricating oil and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-03-25 | — | — | CN | disclosed |
| US-20250043213-A1 | CLEANING FORMULATION | DOW CHEMICAL (CHINA) INVESTMENT COMPANY LIMITED (CN) | 2025-02-06 | — | — | US | disclosed |
| EP-4448709-A1 | CLEANING FORMULATION | Dow Global Technologies LLC (US) | 2024-10-23 | — | — | EP | disclosed |
| US-20240336877-A1 | ANTIFOULANT COMPOSITIONS AND METHOD FOR MITIGATING FOULING IN NATURAL GAS PROCESSING EQUIPMENT | ECOLAB USA INC. (US) | 2024-10-10 | — | — | US | disclosed |
| WO-2024211667-A1 | ANTIFOULANT COMPOSITIONS AND METHOD FOR MITIGATING FOULING IN NATURAL GAS PROCESSING EQUIPMENT | ECOLAB USA INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| US-12095081-B2 | Electrolytic solution and electrochemical device | MURATA MANUFACTURING CO., LTD. (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20120107701-A1 | ELECTROLYTE SOLUTION FOR CHARGEABLE DEVICE, ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY, AND SECONDARY BATTERY | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20110020700-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY CELL, AND SECONDARY CELL | ASAHI GLASS COMPANY, LIMITED (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2270917-A1 | SECONDARY CELL NONAQUEOUS ELECTROLYTE AND SECONDARY CELL | Asahi Glass Company, Limited (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-5557012-A | Fluorination of acetals, ketals and orthoesters | EXFLUOR RESEARCH CORPORATION (US) | 1996-09-17 | — | — | US | disclosed |
| US-5543567-A | Fluorination of acetals, ketals and orthoesters | EXFLUOR RESEARCH CORPORATION (US) | 1996-08-06 | — | — | US | disclosed |
| US-5523496-A | Fluorination of acetals, ketals and orthoesters | EXFLUOR RESEARCH CORPORATION (US) | 1996-06-04 | — | — | US | disclosed |
| EP-0436669-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-07-17 | — | — | EP | disclosed |
| WO-1990003357-A1 | PERFLUOROACETAL AND PERFLUOROKETAL COMPOUNDS AND USE THEREOF IN THERMAL SHOCK TESTING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12597635-B2 | Electrochemical device | CLCN2, HCN4, SLC26A3 | TSHR 1300/4885MEN1 1871/4885KMT2A 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.